We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

113 hedge funds and large institutions have $675M invested in AnaptysBio in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more call options, than puts

Call options by funds: $1.47M | Put options by funds: $1.34M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 36

4% less funds holding

Funds holding: 118 → 113 (-5)

4.51% less ownership

Funds ownership: 115.64% → 111.13% (-4.5%)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

32% less capital invested

Capital invested by funds: $990M → $675M (-$314M)

Holders
113
Holders Change
-5
Holders Change %
-4.24%
% of All Funds
1.8%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
35
Reduced
36
Closed
20
Calls
$1.47M
Puts
$1.34M
Net Calls
+$135K
Net Calls Change
+$64K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$19.2M
2
B
Braidwell
Connecticut
+$6M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$3.88M
4
UOC
UBS O'Connor
Illinois
+$2.81M
5
Goldman Sachs
Goldman Sachs
New York
+$1.9M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$25.1M
2
TCM
Tang Capital Management
California
-$14.5M
3
DM
Deerfield Management
New York
-$13.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.8M
5
LGM
Logos Global Management
California
-$7.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.65M -$8.34K -343 -0.2%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$4.51M +$798K +32,854 +19%
Goldman Sachs
28
Goldman Sachs
New York
$4.04M +$1.9M +78,025 +73%
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$3.47M +$3.88M +159,507 New
Charles Schwab
30
Charles Schwab
California
$3.25M +$13.5K +555 +0.4%
ECM
31
ExodusPoint Capital Management
New York
$2.92M +$943K +38,784 +41%
UOC
32
UBS O'Connor
Illinois
$2.51M +$2.81M +115,479 New
Bank of America
33
Bank of America
North Carolina
$2.5M +$884K +36,383 +46%
Morgan Stanley
34
Morgan Stanley
New York
$2.15M +$66K +2,714 +3%
Macquarie Group
35
Macquarie Group
Australia
$2.04M – – –
Ameriprise
36
Ameriprise
Minnesota
$1.89M +$837K +34,426 +66%
Citadel Advisors
37
Citadel Advisors
Florida
$1.75M -$4.87M -200,323 -71%
Rafferty Asset Management
38
Rafferty Asset Management
New York
$1.68M +$171K +7,040 +10%
N
39
Nuveen
North Carolina
$1.66M -$2.03M -83,479 -52%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$1.65M -$25.3K -1,043 -1%
Renaissance Technologies
41
Renaissance Technologies
New York
$1.56M +$1.74M +71,600 New
Two Sigma Investments
42
Two Sigma Investments
New York
$1.54M +$1.08M +44,310 +166%
Fisher Asset Management
43
Fisher Asset Management
Washington
$1.54M -$168K -6,896 -9%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$1.5M -$435K -17,900 -21%
Citigroup
45
Citigroup
New York
$1.41M +$741K +30,477 +89%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$1.29M +$1.04M +42,760 +262%
SG Americas Securities
47
SG Americas Securities
New York
$1.26M +$580K +23,855 +70%
Ensign Peak Advisors
48
Ensign Peak Advisors
Utah
$945K – – –
Swiss National Bank
49
Swiss National Bank
Switzerland
$803K -$97.2K -4,000 -10%
FWM
50
FMB Wealth Management
California
$774K -$89.1K -3,667 -9%
1
2
3 4 5

ANAB Hedge Fund Activity: Q1 2023 in Review

113 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q1 2023, worth a combined $675M — down 32% from $990M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ANAB and 15 opened new positions — a net loss of 5 holders — while 36 trimmed existing stakes and 35 added.

The largest buyer was Great Point Partners, adding an estimated $19.2M. The largest seller was Federated Hermes, cutting an estimated $25.1M.

  • 113 institutional investors held AnaptysBio (ANAB) as of Q1 2023, down from 118 in Q4 2022.
  • Funds reported $675M of AnaptysBio stock for Q1 2023, down 32% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q1 2023 and 20 closed out, a net change of -5 holders.
  • The largest AnaptysBio buyer in Q1 2023 was Great Point Partners, an estimated $19.2M added.
  • The largest AnaptysBio seller in Q1 2023 was Federated Hermes, an estimated $25.1M sold.

Based on aggregated 13F filings for Q1 2023.